Decentralising Cell Therapies: How Plausible is Point-Of-Care, and How Do We Get There?
11:00am Chair Introduction
Stuart Curbishley, Chief Manufacturing & Development Officer, Adthera Bio
11:05am Presentation: Title to be Confirmed
- Presentation content to be added
Dorothea Ledergerber, Chief Technical Officer, Tigen
11:20am Presentation: Title to be Confirmed
- Presentation content to be added
Presenter to be Confirmed
11:35am Presentation: Title to be Confirmed
- Presentation content to be added
Christian Chabannon, Head of Centre for Cell Therapy, Go CAR-T Coalition
11:50am Presentation: Title to be Confirmed
- Presentation content to be added
Chaminda Salgado, Vice President of CMC, T-Cypher Bio
12:05pm Closing Panel with Q&A
With all session participants
Joined by: Michal Besser, CTO, Davidoff Cancer Center, Rabin Medical Center